Release - Glenmark to initiate Phase I studies forGBR 500 by filing its IND application with the US-FDA 1 of 3 Press Release For Immediate Dissemination Glenmark to initiate Phase.
Release - Glenmark to initiate Phase I studies forGBR 500 by filing its IND application with the US-FDA 1 of 3 Press Release For Immediate Dissemination Glenmark to initiate Phase.
Glenmark Generics Limited Release - Glenmark dermatology line expands with recent U. S. FDA approval Sep 08 1 of 2 Press Release For Immediate Release Glenmark.
Comments (not logged in)